Literature DB >> 10974364

Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior.

M Bohus1, M Limberger, U Ebner, F X Glocker, B Schwarz, M Wernz, K Lieb.   

Abstract

Self-mutilation occurs in 70-80% of patients who meet DSM-IV criteria for borderline personality disorder. Approximately 60% of these patients report that they do not feel pain during acts of self-mutilation such as cutting or burning. Findings of recent studies measuring pain perception in patients with BPD are difficult to interpret since variables such as distress, dissociation or relevant psychotropic medication have not been controlled. The Cold Pressor Test (CPT) and the Tourniquet Pain Test (TPT) were administered to 12 female patients with BPD who reported analgesia during self-mutilation and 19 age-matched healthy female control subjects. All subjects were free of psychotropic medication. The patients were studied on two occasions: during self-reported calmness and during intensive distress (strong urge to cut or burn themselves). Even during self-reported calmness, patients with BPD showed a significantly reduced perception of pain compared to healthy control subjects in both tests. During distress, pain perception in BPD patients was further significantly reduced as compared with self-reported calmness. The present findings show that self-mutilating patients with BPD who experience analgesia during self-injury show an increased threshold for pain perception even in the absence of distress. This may reflect a state-independent increased pain threshold which is further elevated during stress. Interpretation of these findings is limited by their reliance upon self-reports.

Entities:  

Mesh:

Year:  2000        PMID: 10974364     DOI: 10.1016/s0165-1781(00)00179-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  41 in total

1.  Self-mutilation and pharmacotherapy.

Authors:  Brian Daniel Smith
Journal:  Psychiatry (Edgmont)       Date:  2005-10

Review 2.  [Self-injurious behaviour: phenomenology, risk factors, and course].

Authors:  F Petermann; D Nitkowski
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

Review 3.  [Importance of neurobiology for modular psychotherapy].

Authors:  C Schmahl; M Bohus
Journal:  Nervenarzt       Date:  2013-11       Impact factor: 1.214

Review 4.  Psychological Pain, Depression, and Suicide: Recent Evidences and Future Directions.

Authors:  Ismael Conejero; Emilie Olié; Raffaella Calati; Déborah Ducasse; Philippe Courtet
Journal:  Curr Psychiatry Rep       Date:  2018-04-05       Impact factor: 5.285

5.  Invited commentary: understanding brain mechanisms of pain processing in adolescents' non-suicidal self-injury.

Authors:  Elizabeth Ballard; Abigail Bosk; Maryland Pao
Journal:  J Youth Adolesc       Date:  2010-04

6.  Psychobiological response to pain in female adolescents with nonsuicidal self-injury.

Authors:  Julian Koenig; Lena Rinnewitz; Marco Warth; Thomas K Hillecke; Romuald Brunner; Franz Resch; Michael Kaess
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

7.  Assessing Non-Suicidal Self-Injury in the Laboratory.

Authors:  Brooke A Ammerman; Mitchell E Berman; Michael S McCloskey
Journal:  Arch Suicide Res       Date:  2017-06-05

Review 8.  Physical and social pains in borderline disorder and neuroanatomical correlates: a systematic review.

Authors:  Déborah Ducasse; Philippe Courtet; Emilie Olié
Journal:  Curr Psychiatry Rep       Date:  2014-05       Impact factor: 5.285

Review 9.  Components of emotion dysregulation in borderline personality disorder: a review.

Authors:  Ryan W Carpenter; Timothy J Trull
Journal:  Curr Psychiatry Rep       Date:  2013-01       Impact factor: 5.285

Review 10.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.